"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about LAMISIL
• Ask Community about LAMISIL
• LAMISIL Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

LAMISIL Safety Questions, LAMISIL Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LAMISIL. Our extensive database of LAMISIL adverse events and LAMISIL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LAMISIL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

LAMISIL Safety Reports

Total LAMISIL reports: 579.
LAMISIL FDA safety alerts: 2001 .
Reported deaths: 14    Reported hospitalizations: 162.
Take LAMISIL Side Effects Survey or Share Your LAMISIL Story. LAMISIL Usage.

Showing 1-75 of 579 Next >

Physician from UNITED STATES reported LAMISIL problem on June 06, 2006. Male patient, 43 years of age, weighting 194.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholesterol increased, blood glucose increased, chromaturia, disability. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with ACTOS. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Mar 29, 2006. Male patient, 68 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: dermatitis, dermatitis psoriasiform, hyperhidrosis, oedema peripheral, skin lesion. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with LISINOPRIL, TRIAMTERENE, BENICAR, TOPROL, NORVASC, PRAVACHOL, ZETIA, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Mar 27, 2006. Female patient was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: arthralgia, urticaria. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Apr 19, 2006. Female patient was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, systemic lupus erythematosus. LAMISIL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Mar 31, 2006. Female patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, pruritus, urticaria. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 15, 2005. Female patient was diagnosed with tinea pedis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: disease recurrence, rash, skin exfoliation. LAMISIL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Jan 03, 2006. Female patient was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: alopecia, onychoclasis, rash, swelling. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Feb 17, 2006. Male patient, 73 years of age, was diagnosed with tinea pedis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: erythema, oedema peripheral, pain, skin burning sensation, skin oedema, toxic epidermal necrolysis. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with DOXAZOSIN, ENALAPRIL MALEATE, METFORMIN, ALLOPURINOL. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Jan 27, 2006. Female patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: cholestasis, jaundice, liver function test abnormal. LAMISIL dosage: 250 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Feb 10, 2006. Male patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hepatic failure. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Feb 16, 2006. Male patient, 46 years of age, weighting 222.9 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, hepatic enzyme increased. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Feb 09, 2006. Male patient, 70 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. LAMISIL dosage: 250 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Feb 13, 2006. Female patient, 44 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Sept 01, 2006. Female patient, 41 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: angioedema, urticaria. LAMISIL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Mar 17, 2006. Male patient, 56 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pruritus, rash erythematous, skin exfoliation, skin fissures. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Male patient was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pruritus, urticaria. LAMISIL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on June 07, 2006. Male patient, 68 years of age, weighting 213.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: oral discomfort, rash, skin exfoliation, stevens-johnson syndrome. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with KETEK, AVANDIA, LISINOPRIL, LIPITOR, LIMBITROL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on July 11, 2006. Female patient, 54 years of age, weighting 110.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia, decreased appetite, dysgeusia, nausea, weight decreased. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with OPIUM ALKALOIDS AND DERIVATIVES, SYNTHROID. Patient recovered.

Health Professional from UNITED STATES reported LAMISIL problem on Aug 11, 2006. Female patient, 32 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: dermatitis allergic, pyrexia, rash, skin disorder, skin exfoliation, skin haemorrhage, skin lesion, stevens-johnson syndrome, toxic epidermal necrolysis. LAMISIL dosage: 250 MG, ORAL. Patient was hospitalized. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on June 15, 2006. Female patient, 64 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: arthralgia, rash. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2006. Female patient, 33 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pruritus, rash papular, scar, skin discolouration, skin reaction, skin warm. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on June 27, 2006. Female patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: dysgeusia, visual disturbance. LAMISIL dosage: 250 MG, QD,ORAL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on June 30, 2006. Male patient, 56 years of age, weighting 190.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: chills, diarrhoea, fatigue, myalgia, nausea, neutropenia, neutrophil percentage decreased, pyrexia, white blood cell count decreased. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with PRILOSEC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on July 09, 2006. Male patient, 17 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Health Professional from UNITED STATES on Aug 25, 2006. Female patient, 72 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, swelling face. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with CARDIZEM, DYAZIDE. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Aug 02, 2006. Female patient was diagnosed with fungal skin infection and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: petechiae, platelet count decreased, rash. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 57 years of age, weighting 119.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: alopecia totalis, alopecia universalis. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with LANTUS, HUMALOG, EVISTA, CALCIUM, VITAMIN B, VITAMIN E, NAPROXEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Aug 07, 2006. Female patient, 69 years of age, weighting 140.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia, nausea, weight decreased. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2005. Female patient, 29 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: urticaria. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Oct 04, 2005. Female patient, 32 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: urticaria. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2005. Female patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: headache, hypersensitivity, hypokinesia, myalgia, pain, pruritus, urticaria. LAMISIL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Dec 02, 2005. Female patient, 29 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pruritus, urticaria. LAMISIL dosage: 250 MG, ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2006. Female patient, 29 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pruritus, rash papular, skin exfoliation. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Nov 20, 2006. Male patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hepatocellular damage. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 22, 2005. Female patient, 37 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: erythema, hypersensitivity, urticaria. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Nov 30, 2005. Female patient, 78 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: biopsy skin, nail tinea, otorrhoea, overdose, pruritus, rash papular, skin discolouration, skin exfoliation. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with SINGULAIR, LISINOPRIL, AMITRIPTYLINE. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Dec 02, 2005. Female patient was diagnosed with nail tinea, ear infection and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ear infection, hypersensitivity. LAMISIL dosage: 250 MG, QD, ORAL. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LAMISIL problem on Aug 25, 2006. Male patient, 39 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: rash. LAMISIL dosage: unknown. During the same period patient was treated with TYLENOL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Aug 30, 2006. Female patient, 59 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: decreased appetite, diarrhoea, dysgeusia, nausea, vomiting, weight decreased. LAMISIL dosage: 250 MG QD ORAL. During the same period patient was treated with ARIMIDEX, BELLAMINE S, SYNTHROID, TOPROL, MICARDIS HCT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Aug 31, 2006. Male patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, swelling face. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Pharmacist from UNITED STATES on Oct 02, 2006. Female patient, 43 years of age, weighting 119.9 lb, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, arthralgia, arthritis. LAMISIL dosage: unknown. During the same period patient was treated with SYNTHROID, CONTRACEPTIVES UNS. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Sept 27, 2006. Female patient, 36 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia, urticaria. LAMISIL dosage: 250 MG QD ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2006. Male patient, 69 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, dysgeusia, tongue coated, weight decreased. LAMISIL dosage: 250 MG QD ORAL. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Jan 13, 2006. Female patient, 40 years of age, weighting 130.1 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia, anorexia, asthenia, dysgeusia, pain in extremity, stress, tongue dry, weight decreased. LAMISIL dosage: unknown. Patient was hospitalized. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Oct 07, 2005. Male patient, 33 years of age, was diagnosed with body tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, hepatic enzyme increased, jaundice, ocular icterus. LAMISIL dosage: 250 MG QD ORAL. During the same period patient was treated with BACTRIM DS, PREDNISONE. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Nov 03, 2005. Female patient, 67 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia, appetite disorder, dysgeusia, leukopenia, neutropenia. LAMISIL dosage: 250 MG ORAL. During the same period patient was treated with CRESTOR, ACTONEL, EVISTA, SYNTHROID. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Nov 23, 2005. Female patient, 58 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, cutaneous lupus erythematosus, erythema annulare, pruritus, rash, skin exfoliation, thermal burn. LAMISIL dosage: 250 MG QD ORAL. During the same period patient was treated with PREMARIN. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Nov 28, 2005. Female patient, 36 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: erythema, erythema multiforme, pruritus, rash erythematous, skin exfoliation, skin reaction. LAMISIL dosage: 250 MG QD ORAL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Oct 25, 2006. Female patient, 53 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, pruritus, rash erythematous. LAMISIL dosage: 250 MG QD ORAL. During the same period patient was treated with SYNTHROID, ALPRAZOLAM, QUESTRAN LIGHT. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Nov 03, 2005. Male patient, 59 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, hepatitis toxic, pyrexia. LAMISIL dosage: 250 MG QD ORAL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Sept 30, 2005. Male patient, 70 years of age, weighting 224.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pruritus, rash erythematous. LAMISIL dosage: 250 MG QD ORAL. During the same period patient was treated with CYMBALTA, XANAX, VIAGRA. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Oct 04, 2005. Female patient, 13 years of age, weighting 110.0 lb, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: rash papular. LAMISIL dosage: 250 MG QD ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: exfoliative rash, hypersensitivity, rash papular. LAMISIL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on Aug 18, 2006. Female patient, 53 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: ageusia, weight decreased. LAMISIL dosage: 250 MG QD ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Male patient, 26 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hepatocellular damage. LAMISIL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on Apr 13, 2006. Female patient, 37 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, jaundice. LAMISIL dosage: unknown. During the same period patient was treated with SEPTRA DS. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Female patient, 60 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, rash. LAMISIL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on May 05, 2006. Male patient, 59 years of age, weighting 179.9 lb, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: skin exfoliation, skin lesion. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 05, 2006. Female patient, 36 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: cough, pruritus, rash, stridor, urticaria, wheezing. LAMISIL dosage: 250 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on July 31, 2006. Female patient was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: discomfort. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Health Professional from UNITED STATES on May 11, 2006. Female patient, 56 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: systemic lupus erythematosus rash. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LAMISIL problem on May 18, 2006. Female patient, 47 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: chromaturia, decreased appetite, dysgeusia, insomnia, jaundice, laboratory test abnormal, ocular icterus, pruritus. LAMISIL dosage: 250 MG, QD, ORAL. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Sept 06, 2006. Female patient, 52 years of age, weighting 198.0 lb, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: face oedema, pain, periorbital oedema, pruritus, swelling face, urticaria. LAMISIL dosage: unknown. During the same period patient was treated with PREMPRO. Patient recovered.

Physician from UNITED STATES reported LAMISIL problem on June 27, 2006. Female patient, 60 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin exfoliation, skin reaction. LAMISIL dosage: 250 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2006. Female patient, 37 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pruritus. LAMISIL dosage: unknown. Patient recovered.

Physician from JAPAN reported LAMISIL problem on Feb 16, 2007. Female patient, 70 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: aldolase increased, back pain, myalgia. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2007. Female patient, child 8 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: bone marrow disorder, white blood cell count decreased. LAMISIL dosage: 250 MG, QD. Patient recovered.

Physician from JAPAN reported LAMISIL problem on Feb 19, 2007. Female patient, 86 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: eosinophil count increased, haematocrit decreased, haematology test abnormal, haemoglobin decreased, lymphocyte count decreased, monocyte count decreased, red blood cell count decreased. LAMISIL dosage: unknown. During the same period patient was treated with WARFARIN, OMEPRAL, LASIX, FLUITRAN, ALLOPURINOL, ONEALFA, MUCOSTA, JUVELA. Patient recovered.

LAMISIL problem was reported by a Consumer or non-health professional from VENEZUELA on Feb 22, 2007. Male patient, 66 years of age, was diagnosed with nail tinea, fungal skin infection and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, hypertension, somnolence. LAMISIL dosage: unknown. During the same period patient was treated with GLUCOVANCE, TRENTAL, PRETERAX, CONCOR, TELMISARTAN, SOMESE. Patient recovered.

Physician from FRANCE reported LAMISIL problem on Feb 23, 2007. Male patient, 40 years of age, was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: pyrexia. LAMISIL dosage: unknown. Patient recovered.

LAMISIL problem was reported by a Physician from FRANCE on Feb 23, 2007. Female patient, 70 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: purpura, rash macular, rash papular. LAMISIL dosage: unknown. Patient recovered.

Consumer or non-health professional from CHINA reported LAMISIL problem on Feb 27, 2007. Female patient, 32 years of age, was diagnosed with nail tinea and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, genital discharge. LAMISIL dosage: 250 MG, QD. Patient was hospitalized. Patient recovered.

LAMISIL problem was reported by a Physician from UNITED STATES on Feb 26, 2007. Male patient, weighting 150.0 lb, was diagnosed with onychomycosis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, dysgeusia, hypogeusia, nausea, oral intake reduced, weight decreased. LAMISIL dosage: 250 MG, QD. During the same period patient was treated with SYNTHROID, LIPITOR, METOPROLOL SUCCINATE. Patient recovered.

Pharmacist from UNITED STATES reported LAMISIL problem on Feb 26, 2007. Male patient, 73 years of age, was diagnosed with onychomycosis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: blood iron decreased, melaena. LAMISIL dosage: 250 MG, QD. During the same period patient was treated with CARAFATE. Patient recovered.

Showing 1-75 of 579 Next >

Ask Our Patient Community about LAMISIL
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol Prosom (estazolam) Protonix (pantoprazole) Protopic (tacrolimus) Provigil (modafinil) Prozac (fluoxetine) Prussian blue back to top	Q Quazepam Quetiapine Quinapril Quinupristin R Rabeprazole Radiogardase (prussian blue) Ramelteon Ramipril Ranexa (ranolazine) Ranibizumab Ranolazine Rapamune (sirolimus) Raptiva (efalizumab) Rasagiline Razadyne (galantamine) Rebetol (ribavirin) Reclast (zoledronic acid) Refludan (lepirudin recombinant) Relenza (zanamivir) Relpax (eletriptan) Remeron (mirtazapine)